Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Aurinia Pharmaceuticals Ownership Summary

Aurinia Pharmaceuticals is owned by 31.22% institutional investors, 7.14% insiders, and 61.64% retail investors. Tang capital management is the largest institutional shareholder, holding 8.16% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.18% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aurinia Pharmaceuticals	31.22%	7.14%	61.64%
Sector	Healthcare Stocks	42.54%	10.82%	46.64%
Industry	Biotech Stocks	45.21%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tang capital management	11.33M	8.16%	$125.19M
Blackrock	9.27M	6.44%	$52.94M
Blackrock funding, inc. /de	7.45M	5.36%	$82.31M
Nea management company	3.97M	2.86%	$43.87M
Arrowstreet capital, limited partnership	3.37M	2.43%	$37.28M
State street	2.69M	1.94%	$29.77M
Morgan stanley	1.95M	1.40%	$21.51M
Vanguard group	1.56M	1.12%	$17.21M
Geode capital management	1.49M	1.07%	$16.41M
Marshall wace, llp	1.48M	1.07%	$16.39M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tang capital management	11.33M	4.82%	$125.19M
Nea management company	3.97M	2.41%	$43.87M
Ironwood investment management	114.86K	0.55%	$1.27M
City center advisors	32.45K	0.35%	$358.60K
Rice hall james & associates	542.55K	0.33%	$6.00M
Hussman strategic advisors	126.00K	0.30%	$1.39M
Precision wealth strategies	62.04K	0.22%	$685.56K
Virtus fund advisers	7.03K	0.20%	$63.15K
Pdt partners	265.49K	0.18%	$2.93M
Highmark wealth management	37.70K	0.18%	$416.54K

Top Buyers

Holder	Shares	% Assets	Change
Arrowstreet capital, limited partnership	3.37M	0.02%	2.30M
Marshall wace, llp	1.48M	0.02%	1.38M
Tang capital management	11.33M	4.82%	1.30M
Two sigma investments, lp	1.34M	0.02%	1.18M
Blackrock	9.27M	0.00%	609.18K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.63M
Rock springs capital management lp	-	-	-1.18M
Point72 asset management	-	-	-849.62K
Readystate asset management lp	-	-	-657.84K
Morgan stanley	1.95M	0.00%	-449.45K

New Positions

Holder	Shares	% Assets	Change	Value
Voloridge investment management	512.57K	0.02%	512.57K	$5.66M
Hood river capital management	269.31K	0.04%	269.31K	$2.98M
Norges bank	114.05K	0.00%	114.05K	$651.20K
Uniplan investment counsel	91.56K	0.10%	91.56K	$1.01M
Ritholtz wealth management	84.52K	0.02%	84.52K	$933.89K

Sold Out

Holder	Change
Twin peaks wealth advisors	-2.00
Vima	-25.00
Nelson, van denburg & campbell wealth management group	-26.00
Federation des caisses desjardins du quebec	-40.00
Stephens consulting	-45.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	206	-10.04%	43,375,015	-25.50%	31	1.78%	86	-14.00%	77	20.31%
Jun 30, 2025	227	1.79%	58,203,989	-6.12%	41	2.10%	99	-1.98%	64	6.67%
Mar 31, 2025	3	-98.60%	312,556	-99.46%	-	0.01%	1	-99.00%	-	-100.00%
Dec 31, 2024	210	6.60%	57,561,302	-0.09%	40	2.48%	98	16.67%	49	11.36%
Sep 30, 2024	195	7.73%	57,393,945	3.76%	40	2.69%	83	-2.35%	43	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Russell 2000 ETF	2.88M	2.18%	-
Fidelity Small Cap Index	1.18M	0.90%	-178.29K
iShares Russell 2000 Growth ETF	1.04M	0.79%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	833.00K	0.63%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	820.80K	0.60%	-
iShares Biotechnology ETF	715.73K	0.54%	-
Lazard US Sm Cap Eq WW Dist EUR	577.32K	0.43%	58.09K
Vanguard Russell 2000 ETF	555.52K	0.42%	-44.21K
International Biotechnology Ord	534.69K	0.41%	-
Vanguard Explorer Inv	425.41K	0.31%	134.96K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 05, 2025	TANG KEVIN	-	Buy	$2.34M
Aug 01, 2025	TANG KEVIN	-	Buy	$10.12M
Aug 04, 2025	TANG KEVIN	-	Buy	$1.13M
Aug 01, 2025	Keenan Greg	Chief Medical Officer	Sell	$210.00K
Mar 07, 2025	Keenan Greg	Chief Medical Officer	Sell	$68.35K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	3	1
2025 Q2	-	-
2025 Q1	6	10
2024 Q4	3	2
2024 Q3	-	1

AUPH Ownership FAQ

Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 31.22%, followed by 7.14% insiders and 61.64% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 45.21%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Tang capital management (11.33M shares, 8.16%), Blackrock (9.27M shares, 6.44%), and Blackrock funding, inc. /de (7.45M shares, 5.36%). Together, they hold 19.96% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.82% of its assets in 11.33M Aurinia Pharmaceuticals shares, valued at 125.19M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.18% of its total shares outstanding invested in 2.88M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools